Search Menu
Photonics Media Photonics Buyers' Guide Photonics Spectra BioPhotonics EuroPhotonics Vision Spectra Photonics Showcase Photonics ProdSpec Photonics Handbook
More News

Minimally Invasive Devices Inc. (MID)

Facebook Twitter LinkedIn Email Comments
Minimally Invasive Devices Inc. (MID) of Columbus, Ohio, has raised an additional $2.5 million from Radius Ventures, topping off its Series B financing at $11.5 million. The Series B originally raised $9 million in a financing led by Canaan Partners with participation by existing investor Charter Life Sciences. FloShield, MID’s flagship laparoscopic vision system, maintains a clear field of vision from beginning to end in laparoscopic surgery procedures. The technology easily attaches to modern HD vision systems, enabling surgery to occur without interruption, loss of vision, or scope removal for cleaning. Such removals are time-consuming, interfere with the OR team’s focus, and frequently occur during critical points in surgery when optimal vision is critical, leading to surgeon frustration. Funds will be used for sales and marketing, clinical studies, the generation of outcomes data and additional product development.

Sep 2013
AmericasBiophotonicsBusinessCanaan PartnersCharter Life SciencesFloShieldimaginglaparoscopic surgeryMIDMinimally Invasive DevicesRadius VenturesRapidScan

back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2020 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA,

Photonics Media, Laurin Publishing
x Subscribe to BioPhotonics magazine - FREE!
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.